Abbott Laboratories Stock

Abbott Laboratories EBIT

The EBIT of Abbott Laboratories (ABT) as of Aug 25, 2026 is 8.23 B USD. In the previous year, EBIT was 7.04 B USD — a change of 16.95% (higher).

EBIT

8.23 BUSD

YoY

16.95%

Last updated:

In 2026, Abbott Laboratories's EBIT was 8.23 B USD, a 16.95% increase from the 7.04 B USD EBIT recorded in the previous year.

The Abbott Laboratories EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2023
6.68 B USD
Jan 1, 2024
7.04 B USD
Jan 1, 2025
8.23 B USD
Jan 1, 2026 (e)
9.67 B USD
Jan 1, 2027 (e)
10.52 B USD
Jan 1, 2028 (e)
11.25 B USD
Jan 1, 2029 (e)
12.09 B USD
Jan 1, 2030 (e)
12.93 B USD
The Abbott Laboratories EBIT history
YEAREBITYoY
est12.93 BUSD+6.98%
est12.09 BUSD+7.48%
est11.25 BUSD+6.92%
est10.52 BUSD+8.73%
est9.67 BUSD+17.50%
8.23 BUSD+16.95%
7.04 BUSD+5.34%
6.68 BUSD-20.08%
8.36 BUSD-9.11%
9.20 BUSD+73.88%
5.29 BUSD+15.25%
4.59 BUSD+19.43%
3.84 BUSD+39.68%
2.75 BUSD-15.30%
3.25 BUSD+10.17%
2.95 BUSD+1.13%
2.92 BUSD+35.88%
2.15 BUSD+6.93%
2.01 BUSD-70.66%
6.84 BUSD-2.97%
7.05 BUSD+7.31%
6.57 BUSD+7.91%
6.09 BUSD+23.12%
4.95 BUSD+14.05%
4.34 BUSD
Access this data via the Eulerpool API

Abbott Laboratories Revenue

Abbott Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
40.11 B USD
6.68 B USD
5.72 B USD
Jan 1, 2024
41.95 B USD
7.04 B USD
13.40 B USD
Jan 1, 2025
44.33 B USD
8.23 B USD
6.52 B USD
Jan 1, 2026 (e)
50.31 B USD
9.67 B USD
9.64 B USD
Jan 1, 2027 (e)
54.70 B USD
10.52 B USD
10.60 B USD
Jan 1, 2028 (e)
58.48 B USD
11.25 B USD
11.75 B USD
Jan 1, 2029 (e)
62.86 B USD
12.09 B USD
13.03 B USD
Jan 1, 2030 (e)
67.25 B USD
12.93 B USD
14.46 B USD

Abbott Laboratories Margins

Abbott Laboratories stock margins

The Abbott Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Abbott Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Abbott Laboratories.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
49.96 %
16.66 %
14.27 %
Jan 1, 2024
50.83 %
16.78 %
31.95 %
Jan 1, 2025
55.51 %
18.57 %
14.72 %
Jan 1, 2026 (e)
55.51 %
19.23 %
19.16 %
Jan 1, 2027 (e)
55.51 %
19.23 %
19.37 %
Jan 1, 2028 (e)
55.51 %
19.23 %
20.09 %
Jan 1, 2029 (e)
55.51 %
19.23 %
20.73 %
Jan 1, 2030 (e)
55.51 %
19.23 %
21.51 %

Abbott Laboratories Stock analysis

What does Abbott Laboratories do? Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Abbott Laboratories's EBIT

Abbott Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Abbott Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Abbott Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Abbott Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Abbott Laboratories stock

EBIT of Abbott Laboratories is 8.23 B USD in 2026.

EBIT of Abbott Laboratories changed from 7.04 B USD to 8.23 B USD, representing a 16.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Abbott Laboratories since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Abbott Laboratories historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Abbott Laboratories

All Key Metrics — Abbott Laboratories